Evidence For Healthcare Improvement

Icer analytics is a cloud-based platform that facilitates the use of icer's evidence reports and underlying analyses to help all americans achieve sustainable access to high-value care. Available on a subscription basis, the platform provides pharmaceutical manufacturers, private and public payers, clinicians, patients, and other stakeholders, with a suite of tools that streamline interpretation of icer's analyses, directly from the source, all designed to support integration into users' own pricing, reimbursement, and clinical work. Icer analytics subscribers have access to icer's price benchmarks, cost-effectiveness results, comparative clinical effectiveness judgments, policy recommendations, and economic models within two primary tools the evidence compendium and the interactive modeler.

The policy leadership forum ("plf") was launched to give a select number of leading health care organizations a unique opportunity to shape the future of evidence and coverage policy in the united states. The tension between innovation and health care costs continues to focus critical attention on how evidence will be developed by manufacturers and how it will be interpreted by payers in making coverage decisions. Benefiting from icer's experience as a leader in health technology assessment, and its unique ability to serve as an engaged, objective convener and moderator, plf brings together a small, influential group of evidence leaders from insurers, pharmacy benefit management firms, health technology assessment groups, and life science companies to address key controversies in evidence methods and policy. Working together in a balanced, nonadversarial environment, plf members contribute to the development of influential policy recommendations while enhancing the skills, insights, and relationships necessary to strengthen their competitive position in the marketplace. Dues from plf members support icer's annual policy summit and do not contribute to funding for icer's value assessments.